Thank you for breaking it out. Analyst estimates (on average) were that MNTA would lose 5 cents per share this quarter (interestingly, the high estimate had MNTA making 5 cents per share this quarter).
Clearly the analysts had this all wrong.
That being said, there is some disparity between your profit expectations and that of Dew. Assuming MNTA's share of Lovenox sales = $40 million and that they receive the one time $5 million in royalty payments, and continue to burn 13 million in burn, quarterly profit would be closer to $32 million (66 cents per share). (40+5-13 = 32) Very hefty! Using your PE multiplier of 15, you'd get closer to $40 per share. Add copaxone and m118 in there, and you do get pretty close to $70.
Market Data 
Markets 
AI
